Article ID Journal Published Year Pages File Type
2711872 Journal of Stroke and Cerebrovascular Diseases 2008 6 Pages PDF
Abstract
For patients with stroke and a perfusion-/diffusion-weighted imaging mismatch treated with intravenous tissue plasminogen activator at 3 to 6 hours, a substantial change in the baseline NIHSS score (≥10 points) is a potent discriminator of patients who experience early reperfusion from those who do not. In addition, an NIHSS score of less than or equal to 2 appears to be an excellent end point for phase II studies of reperfusion therapies.
Related Topics
Health Sciences Medicine and Dentistry Clinical Neurology
Authors
, , , , , , , , ,